Aquestive Therapeutics (AQST): Operating Profitability

Aquestive Corp (AQST) - corporate logo

Aquestive Therapeutics (AQST) does not pay dividends, focusing instead on the defensive epilepsy therapy segment characterized by stable demand. On GURU.Markets, the operating margin curve serves as a confidence indicator, with the metric currently standing at -114.10. Business growth relies on proprietary PharmFilm soluble films, which create an ecosystem for partners, while the company actively expands its network of external contractors to optimize logistics.

AQST - aquestive.com Operating Profit Ratio over the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Aquestive Therapeutics (AQST)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:Aquestive Pharma
Brand item of Aquestive Corp

Operating margin measures the efficiency of profit generation from core business processes relative to revenue. The operating margin indicator visualizes the dynamics of the alpha factor, where extreme values signal impending volatility. This metric is calculated as the ratio of operating income to sales, reflecting internal profitability. High sensitivity of this indicator is critical for Aquestive Therapeutics (AQST). This is driven by colossal R&D expenditures and strict FDA oversight of proprietary PharmFilm films.

Competitor analysis for Aquestive Therapeutics

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.